Published in Breast Cancer Res Treat on January 01, 2002
Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA (2009) 2.42
Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting. Fam Cancer (2009) 0.97
Screening behavior in women at increased familial risk for breast cancer. Fam Cancer (2006) 0.97
Influence of perceived breast cancer risk on screening behaviors of female relatives from the Ontario site of the Breast Cancer Family Registry. Eur J Cancer Prev (2011) 0.91
Adherence to breast and ovarian cancer screening recommendations for female relatives from the Ontario site of the Breast Cancer Family Registry. Eur J Cancer Prev (2011) 0.87
Breast cancer recurrence risk reduction beliefs in breast cancer survivors: prevalence and relation to behavior. Psychooncology (2011) 0.86
Native human autoantibodies targeting GIPC1 identify differential expression in malignant tumors of the breast and ovary. BMC Cancer (2008) 0.85
Components of family history associated with women's disease perceptions for cancer: a report from the Family Healthware™ Impact Trial. Genet Med (2011) 0.84
Worry is good for breast cancer screening: a study of female relatives from the ontario site of the breast cancer family registry. J Cancer Epidemiol (2012) 0.80
Breast cancer knowledge and early detection among Hispanic women with a family history of breast cancer along the U.S.-Mexico border. J Health Care Poor Underserved (2010) 0.80
Predictors of choosing life-long screening or prophylactic surgery in women at high and moderate risk for breast and ovarian cancer. Fam Cancer (2008) 0.77
Breast and cervical cancer screening in Great Britain: Dynamic interrelated processes. Health Econ Rev (2015) 0.77
The impact of cancer prevention guideline adherence on overall mortality in a high-risk cohort of women from the New York site of the Breast Cancer Family Registry. Breast Cancer Res Treat (2015) 0.76
Diet and predictors of dietary intakes in women with family history of breast and/or ovarian cancer. Cancer Epidemiol (2009) 0.75
Impact of Genetic Counseling and Testing on Altruistic Motivations to Test for BRCA1/2: a Longitudinal Study. J Genet Couns (2015) 0.75
Health Care Utilization, Lifestyle, and Emotional Factors and Mammography Practices in the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev (2015) 0.75
Efficacy of a device to narrow the coronary sinus in refractory angina. N Engl J Med (2015) 5.36
BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol (2002) 4.38
Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol (2004) 3.88
Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol (2006) 3.73
Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Arch Gen Psychiatry (2008) 3.12
Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Ann Intern Med (2010) 2.94
The role of trust in use of preventive services among low-income African-American women. Prev Med (2004) 2.90
Decision making in prostate cancer screening using decision aids vs usual care: a randomized clinical trial. JAMA Intern Med (2013) 2.38
Varenicline improves mood and cognition during smoking abstinence. Biol Psychiatry (2008) 2.29
Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet A (2003) 2.29
Association of attention-deficit/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents. J Am Acad Child Adolesc Psychiatry (2002) 2.19
Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol (2002) 2.13
Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Hum Mol Genet (2008) 2.12
Neural substrates of abstinence-induced cigarette cravings in chronic smokers. J Neurosci (2007) 2.11
Transcatheter treatment for refractory angina with the Coronary Sinus Reducer. EuroIntervention (2014) 2.07
Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes. J Neurogenet (2009) 2.07
All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet (2002) 2.05
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomarkers Prev (2011) 1.99
Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures. Exp Clin Psychopharmacol (2007) 1.94
Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med (2007) 1.94
A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiol Biomarkers Prev (2006) 1.93
Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol (2014) 1.91
Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Pharmacol Biochem Behav (2008) 1.90
New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure. Drug Alcohol Depend (2006) 1.85
Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. Proc Natl Acad Sci U S A (2009) 1.76
The use of race variables in genetic studies of complex traits and the goal of reducing health disparities: a transdisciplinary perspective. Am Psychol (2005) 1.71
Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology (2003) 1.70
Cigarette smoking practices among American college students: review and future directions. J Am Coll Health (2004) 1.69
A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol (2002) 1.69
Relationship between education and delay discounting in smokers. Addict Behav (2004) 1.65
Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM). Nicotine Tob Res (2008) 1.62
Medication screening for smoking cessation: a proposal for new methodologies. Psychopharmacology (Berl) (2005) 1.62
Barriers to translating emerging genetic research on smoking into clinical practice. Perspectives of primary care physicians. J Gen Intern Med (2005) 1.54
Working memory deficits predict short-term smoking resumption following brief abstinence. Drug Alcohol Depend (2009) 1.53
Is endoscopy necessary for the measurement of disease activity in ulcerative colitis? Am J Gastroenterol (2005) 1.52
Non-replication of genetic association studies: is DAT all, folks? Nicotine Tob Res (2002) 1.50
Interacting effects of genetic predisposition and depression on adolescent smoking progression. Am J Psychiatry (2004) 1.50
CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial. Biol Psychiatry (2007) 1.48
Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med (2004) 1.48
Parent-child factors and their effect on communicating BRCA1/2 test results to children. Patient Educ Couns (2002) 1.47
CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Arch Gen Psychiatry (2007) 1.44
Comparison between two measures of delay discounting in smokers. Exp Clin Psychopharmacol (2003) 1.42
Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance. Cancer (2011) 1.41
Food hedonics and reinforcement as determinants of laboratory food intake in smokers. Physiol Behav (2004) 1.41
Initial nicotine sensitivity in humans as a function of impulsivity. Psychopharmacology (Berl) (2008) 1.40
Facilitating transdisciplinary research: the experience of the transdisciplinary tobacco use research centers. Nicotine Tob Res (2003) 1.39
Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. J Clin Oncol (2003) 1.38
Smoking topography predicts abstinence following treatment with nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev (2004) 1.38
Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biol Psychiatry (2010) 1.38
An association of CYP2A6 genotype and smoking topography. Nicotine Tob Res (2007) 1.37
Current and emerging pharmacotherapies for treating tobacco dependence. Expert Opin Emerg Drugs (2006) 1.35
Behavioral consequences of testing for obesity risk. Cancer Epidemiol Biomarkers Prev (2005) 1.35
Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers. Am J Clin Nutr (2004) 1.34
Individual differences in nicotine intake per cigarette. Cancer Epidemiol Biomarkers Prev (2003) 1.32
Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial. Genet Test (2008) 1.31
Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction. Health Psychol (2009) 1.30
Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proc Natl Acad Sci U S A (2011) 1.29
Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy. J Subst Abuse Treat (2005) 1.28
Influence of methylphenidate on eating in obese men. Obes Res (2004) 1.27
Association of retrospective early smoking experiences with prospective sensitivity to nicotine via nasal spray in nonsmokers. Nicotine Tob Res (2008) 1.27
Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users. Nicotine Tob Res (2009) 1.27
Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. Nicotine Tob Res (2007) 1.26
Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. Pharmacogenet Genomics (2013) 1.24
Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients. Cancer Epidemiol Biomarkers Prev (2005) 1.24
Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling. Nicotine Tob Res (2004) 1.24
Treating tobacco dependence in women. J Womens Health (Larchmt) (2007) 1.23
Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood. Behav Pharmacol (2008) 1.22
Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing. J Clin Oncol (2006) 1.22
Experimental evaluation of antitobacco PSAs: effects of message content and format on physiological and behavioral outcomes. Nicotine Tob Res (2009) 1.21
Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. Nicotine Tob Res (2007) 1.21
Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results. Am J Med Genet C Semin Med Genet (2006) 1.21
Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion. Nicotine Tob Res (2005) 1.20
Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors. Breast Cancer Res Treat (2006) 1.20
Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2010) 1.19
Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence. Biol Psychiatry (2006) 1.18
Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence. Neuropsychopharmacology (2010) 1.17
Reduced prefrontal and temporal processing and recall of high "sensation value" ads. Neuroimage (2009) 1.17
Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patients. Psychooncology (2004) 1.17
Facilitating clinical implementation of pharmacogenomics. JAMA (2011) 1.16
Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children. Genet Test (2007) 1.16
The effect of smoking cues in antismoking advertisements on smoking urge and psychophysiological reactions. Nicotine Tob Res (2009) 1.15
Evaluating smokers' reactions to advertising for new lower nicotine quest cigarettes. Psychol Addict Behav (2006) 1.15
Nicotine vaccines: will smokers take a shot at quitting? Nicotine Tob Res (2010) 1.15
Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials. Neuropsychopharmacology (2011) 1.15
Patient satisfaction with cancer genetic counseling: a psychometric analysis of the Genetic Counseling Satisfaction Scale. J Genet Couns (2004) 1.14
Pharmacogenetics and nicotine addiction treatment. Pharmacogenomics (2005) 1.13